ocular disorder
Abu Dhabi Health Department, Opus Genetics Strike Gene Therapy Collaboration for Retinal Diseases
The organizations will explore opportunities to conduct preclinical and clinical trials in the UAE and leverage the UAE's genome program.
University of Manchester, Sano Genetics to Research Eye Diseases
The partners plan to build a database of genomic and patient-reported data to identify how genetics can impact disease outcome.
Avellino Labs Gets CLIA Certification
With the certification, the Silicon Valley-based company aims to roll out its AvaGen test for keratoconus and corneal dystrophies beginning this quarter.
Editas, Allergan Ink $90M CRISPR-Based Eye Drug Deal
Allergan will have the exclusive rights to license certain of Editas' CRISPR genome editing-based treatments for eye diseases.
Scientists Exploit SNP to Create New CRISPR/Cas9 Editing Site in Corneal Dystrophy Gene
They successfully edited the gene in mice in vivo and their approach could also work for a range of heterozygous disease-causing SNPs.
Nov 24, 2014
Jun 30, 2011